Severe tophaceous gout and disability: changes in the past 15 years

Clin Rheumatol. 2017 Jan;36(1):199-204. doi: 10.1007/s10067-016-3381-z. Epub 2016 Sep 8.

Abstract

Epidemiologic data from recent decades show a significant increase in the prevalence and incidence of gout worldwide, in addition to changes in its clinical expression. Our objective was to compare the frequency of the severity of gout and disability in two patient groups at our clinic during different periods. We included and compared data of two groups: group A (1995-2000), patients from previous report, and group B (2010-2014), the baseline data of current patients participating in a cohort (GRESGO). This evaluation included data of socioeconomic and educational levels, demographics, associated diseases, previous treatment, clinical and biochemical data, and disability evaluated using the Health Assessment Questionnaire (HAQ). We included data of 564 gout patients. Participants were 35.7 ± 12.7 years old at onset and had 12.0 ± 9.2-years disease duration at their first evaluation in our department. Group B patients were younger, had higher educational and socioeconomic levels, and had more severe disease. However, this group had less frequency of some associated diseases and significantly higher HAQ scores. With increased HAQ score, a higher number of acute flares and tender, limited-to-motion, and swollen joints were seen. The spectrum of gout has changed over the past decade. A higher percentage of our patients had a severe form of disease, were younger, had earlier disease onset, and had more disability reflected in higher HAQ scores. In our current patient group, the variable most associated with disability was limited-to-motion joints; however, the number of acute flares and tender and swollen joints was also higher in patients with greater disability.

Keywords: Disability; Gout; HAQ; Tophaceous gout.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Cohort Studies
  • Disability Evaluation
  • Disabled Persons*
  • Female
  • Gout / diagnosis*
  • Gout / epidemiology
  • Gout / physiopathology*
  • Humans
  • Joints / physiopathology
  • Male
  • Mexico / epidemiology
  • Middle Aged
  • Retrospective Studies
  • Rheumatology / methods
  • Rheumatology / trends
  • Surveys and Questionnaires
  • Young Adult